Sneha Jay Shah, MS, FAICO

Sneha Jay Shah, MS, FAICO

Contact information

Locations
  • Prince Aly Khan Hospital
    Nesbit road, Mazgaon, Mumbai, Maharashtra 400010
    (22) 23777800, 23777900
    Map and directions »
Facebook

LinkedIn

Specialty
Ophthalmic Oncologist

Education and Fellowships

Fellowship
Centre for sight, Hyderabad, India
Fellowship
L V Prasad Eye Institute, Hyderabd, India
Fellowship
Sankara Nethralaya

Current Positions

Consultant Ocular Oncologist and Oculoplastic Surgeon


Biography

Dr Sneha J. Shah completed her postgraduation in Ophthalmology and was the silver medalist in the university. Her interest in Oculoplastics took her to LV Prasad eye institute, Hyderabad, which is a premier eye institute in India, to pursue training in Oculoplastics and Ocular Oncology. She was closely involved with the National Retinoblastoma Registry under the aegis of ICMR. She went on to gain further experience in the field, under her mentor Dr Santosh Honavar at Centre for Sight, Hyderabad. She travelled to USA to enhance her training in Facial Aesthetics at Austin, Texas and Cincinnati, Ohio.
She has carried out research in eyelid tumors and ocular surface tumors and was invited to present a paper on Sebaceous Gland Tumors at the Annual conference of American Academy of Ophthalmology in 2013. She has over 20 presentations and posters in various national and international conferences and 5 publications in peer-reviewed indexed journals.
She is well trained in all aspects of Ophthalmic plastic surgery, including eyelid disorders, lacrimal disorders, trauma, reconstructive surgeries, Ocular oncology and Facial Aesthetics including blepharoplasty, brow lift, botox and fillers. She is abreast with the latest management protocols and believes in evidence based practice.


Selected publications

  • Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor).
    Clinical & histopathologic features in 56 patients with periocular sebaceous carcinoma were analyzed. Immunohistochemical staining with pan-cytokeratin(CK), epithelial membrane antigen (EMA), Ber-EP4, adipophilin (ADP), & AR was compared with that of squamous cell carcinoma (n = 25) and basal cell carcinoma (n = 18).We found that Immunostaining is useful in diagnosing sebaceous carcinoma and differentiating it from SCC and BCC, which are common & sometimes are morphologically identical to SC.
  • Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance?
    56 patients with a biopsy-proven periocular SGC were studied. Immunohistochemical staining for AR, survivin, p53 and Ki-67 was done in all cases. Expression of androgen receptor (AR) and nuclear survivin (NS) was correlated with histopathological features, markers of apoptosis and proliferation and with clinical outcomes. We concluded that Expression of AR significantly impacts prognosis and is thus promising prognostic marker in periocular SGC.
  • Primary intraocular malignant extrarenal rhabdoid tumor: a clinicopathological correlation.
    Malignant extrarenal rhabdoid tumor is a rare and highly aggressive tumor of childhood. Intraocular involvement by malignant extrarenal rhabdoid tumor has only been described once as a metastasis. No report exists in published literature describing a primary intraocular malignant extrarenal rhabdoid tumor. The authors report the first such case along with its clinico-radiological features and histopathologic and electron microscopic characteristics.
  • Squamous Cell Carcinoma of Cornea: Diagnosed on Cytology.
    This case is reported for its rarity and for emphasizing that rapid, simple and minimally invasive technique like scrape cytology can be effective in pre or intra operative diagnosis of ocular surface squamous neoplasia thus helping in intra operative decisions regarding resection margins and post operative management.

The Eye Cancer Network is supported by The Eye Cancer Foundation.
Help support eye cancer research and education now »